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Loss of cellular integrity is a hallmark of severe pathogenic
insults and leads to the activation of immune defenses aimed at
repairing tissue damage and fighting infections. It has been
postulated that the release of danger signals by damaged cells
could lead to the mounting of immune defenses [1e3]. These
danger signals also known as damage associated molecular
pattern (DAMPs) are molecules that trigger specific receptors
including receptors that initiate inflammatory and immune
responses. Many DAMPs are nuclear proteins such as HMGB1
or cytosolic molecules including, for example, uric acid and
ATP. When released outside of the cell following tissue injury,
DAMPs are sensed by immune cells and trigger innate
immune receptors such as the Toll-like receptors (TLRs) or the
NLRP3 inflammasome [4,5]. The release of DAMPs by cells is
often described as a passive process, occurring as a conse-
quence of sustained cell damage. This process is irreversible
and correlates with the death and elimination of the damaged
cell. However, before losing membrane integrity, cells can
experience various states of malfunction that are reversible.* Tel.: þ41 21 692 5695; fax: þ41 21 692 5705.
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cells are malfunctioning, but are also characterized by the
activation of adaptation responses to the stress aimed at
repairing cell damage. Stress can be a consequence of
perturbations in basic cellular functions including the avail-
ability of nutrients and oxygen as well as the capacity to
communicate with neighboring cells and to respond to changes
in the microenvironment. If the cell is able to sense these
perturbations it mounts a response (hereby referred to as
a stress response) that, by definition, is an active cellular
adaptation to the abnormal conditions. If this repair/adaptation
fail or if the stress is too severe, the cell will eventually die
possibly releasing DAMPs. Tissue stress and malfunction
promotes low-grade inflammation which helps the tissue to
adapt to the damage and restore tissue function [6,7]. This
low-grade inflammation also termed para-inflammation illus-
trates how stress and possibly stress response pathways can
contribute to immune responses (Fig. 1). However the mech-
anisms and the role of stress responses in controlling innate
immunity and inflammatory pathways are poorly understood.
The endoplasmic reticulum (ER) is emerging as a key
organelle that maintains cellular homeostasis and contributes
to the regulation of innate immune response [1,8,9]. Pertur-
bations that affect the ER trigger a specific response known as
the ER-stress response. In this review we discuss howsson SAS. All rights reserved.
Fig. 1. Regulation of innate immune signaling by stressed and damaged cells.
The state of a tissue can range from healthy, to stressed or malfunctioning, to
irreversibly damaged. Damaged cells release DAMP, that directly engage
innate immune receptors such as TLRs, NLRs or RAGE receptors. In contrast,
tissue stress or malfunction is a reversible state that triggers an adaptation
response aimed at restoring tissue homeostasis. Stressed tissue may also
trigger danger signals or stress signals that could contribute to the upreglation
of inflammatory and innate immune responses.
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how perturbations and signaling pathways emerging from this
organelle regulate innate and inflammatory pathways.
2. The endoplasmic reticulum (ER)
The ER is an essential organelle that controls the biogenesis
of cellular components including proteins, lipids and carbo-
hydrates. It is connected with the nuclear membrane and via
mitochondria associated membranes (MAMs) to the power
source of the cell: the mitochondria. In eukaryotes, resident
proteins of the endocytic and exocytic organelles as well as
cell surface and secreted proteins are synthetized on poly-
somes anchored to ER membrane and then, translocated across
the membrane into the ER lumen. The ER lumen is rich in
calcium and its oxidizing environment catalyzes post-
translational modifications such as the addition of N-linked
glycans and the formation of disulfide bonds [10,11]. The
nascent protein must fold via a complex process that is
monitored by resident EReprotein chaperones and enzymes
that prevent aggregation and regulate proper folding of newly
synthetized proteins. This process being essential for the
production of virtually every secreted protein and membrane
receptor, the ER is therefore an essential hub controlling
various aspect of cellular biology including virtually all
aspects of cellecell communication and signal transduction
pathways steaming from membranes. In Immunology the ER
is best known for its role in antigen presentation, it is the main
site for the assembly of MHC class I and MHC class II
molecules and is the location of peptide loading onto MHC
class I molecules.
3. The ER-stress response
Conditions of ER stress occur when the amount of proteins
entering the ER exceeds its folding capacity. This imbalance
induces a protective signaling cascade collectively termed theunfolded protein response (UPR) or the ER-stress response
[12,13]. Experimentally, many conditions can trigger the ER-
stress response. For example, conditions that inhibit glyco-
sylation including low glucose as well as pharmacological
compounds such as tunicamycin, affect the maturation and
transport of most secreted proteins causing ER-stress. Other
drugs and conditions that perturb ER Ca2þ levels have
profound effects on ER homeostasis and protein folding.
Drugs such as thapsigargin can trigger depletion of ER
calcium stores leading to acute ER-stress responses. The ER
presents an oxidizing environment that can favor protein
folding and the formation of disulfide bonds. Reducing agents
such as dithiothreitol (DTT) affect the oxidizing potential of
the ER leading to the accumulation of misfolded proteins and
the subsequent engagement of the ER-stress response. In
addition, various physiological and pathological insults that
perturb the cell protein homeostasis network, a group of
interconnected pathways collectively termed the proteostasis
network may trigger the ER-stress response [14,15]. These
insults include alterations in cellular pH, inhibition of the
proteasome pathways, infections with various pathogens as
well as metabolic changes associated with cancer. ER-
signaling pathways and the ER-stress response are among
the major and best-characterized components of the protea-
stasis network pathways.
The ER-stress response is a highly controlled process that
adapt to specific insults to optimize and orchestrate an
appropriate response. While this response may differ from one
condition to another, a general picture of signaling events
emerge. The attenuation of translation is among the first things
that are observed upon induction of ER-stress. This occurs
within minutes to hours of ER-stress activation and prevent
further translational overload of the ER. Perturbation of ER-
homeostasis also results in the up-regulation of genes
involved in ER biogenesis, in chaperoning and folding of
proteins as well as in the quality control mechanisms that
target and ensure elimination of malfunctioning proteins
including the endoplasmic-reticulum-associated protein
degradation (ERAD) pathway. The aim of these responses is to
help the cell cope with the stress, remove the accumulated
protein load, increase ER capacity and restore normal function
of the ER. In conditions of acute and prolonged stress, the
response changes from promoting survival to inducing cell
death. The point at which the ‘apoptotic switch’ is activated
has not yet been determined, and may vary form cell to cell.
The mechanisms of ER-stress mediated apoptosis are yet
poorly understood but may involve the intrinsic apoptotic
pathway that lead to release of cytochrome c from the mito-
chondria and activation of the caspase-9 apoptosome [16e18].
4. ER-signaling pathways
In mammalian cells, the ER-stress response is mediated by
at least three signaling pathways that operate in parallel
(Fig. 2). Each pathway steams from a class of transmembrane
proteins anchored at the ER: IRE1 (Inositol-requiring enzyme
1) PERK (PKR-like ER kinase), and ATF6 (activating
Fig. 2. ER-stress signaling pathways. Accumulation of unfolded proteins or
loss of homeostasis in the ER triggers a stress response that activates ER-
signaling pathways including IRE1, ATF6, and PERK. Active IRE1 lead to
an unconventional splicing of the transcription factor XBP1 and the translation
of an active transcription factor. IRE1 can also activate additional pathways
such as the degradation of ER-related mRNAs through a process termed
RIDD. PERK activation induces the translation of the transcription factor
ATF4 and dampen the translation initiator factor ElF2a activity, leading to
decreased translation and protein synthesis. PERK also promotes the activation
of the transcriptional regulator NRF2. The transcriptionally active form of
ATF6 is produced by proteolysis. When these three main pathways are acti-
vated simultaneously they orchestrate the ER-stress response characterized by
the transcriptional induction of genes aimed at restoring ER homeostasis. The
outcome of the response is repair or, if repair fails, cell death and apoptosis.
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branches control the expression of a few proximal ER-stress
related transcription factors and signaling events that orches-
trate the transcriptional upregulation of the universe of genes
involved in restoring ER functions [16,19,20].
IRE1 is the most conserved branch, the only one present in
lower eukaryotes and probably the best-studied branch of the
ER-stress response. In yeast, IRE1 triggers the full ER-stress
response program, whereas in higher eukaryotes the program
requires cooperation between the three branches of the
ER-stress response. IRE1 transmembrane region is flanked by
a sensor unit at its N-terminus that localize in the ER lumen
and a C-terminal portion that reside in the cytosol. The cyto-
solic portion of IRE1 contains two functional units: a Ser/Thr
protein kinase and an endoribonuclease. Oligomerization of
IRE1 at the ER, triggers its ribonuclease activity and cleaves,
at two closely located and distinct sites, the mRNA of the
X-box binding protein-1 (XBP1) gene. This cleavage results in
the excision of a mini intron of 26 nucleotides in mammals.
Upon ligation, mature XBP1 mRNA encodes a functional
transcription factor. IRE1 mediated removal of the 26 nucle-
otides mini intron open a new translation reading frame at the
C-terminus of the protein coding for a potent transactivation
domain. Therefore, by a unique mechanism in mammals,
unrelated to regular splicing, IRE1 converts an inactive XBP1protein sequence into an active transcription factor. Active
XBP1 referred hereby as XBP1s, contribute to the regulation
of genes involved in different processes including protein
folding, mechanisms controlling protein quality as well as
a broad array of genes involved in almost every aspect of ER
function, physiology and biogenesis [21,22]. Early studies on
XBP1 highlighted the role of the ER-stress response pathways
in the development and regulation of secretory cells including
plasma B cells. XBP1-deficient B cells are unable to differ-
entiate into antibody-secreting plasma cells [23,24] and anti-
body production in vivo in response to antigenic challenge is
impaired by XBP1 deficiency. Importantly it was shown that
activated B cells undergo XBP1 mRNA maturation to produce
XBP1s in order to promote ER expansion and develop the
secretory capacity of plasma cells [25,26]. However, what
drives IRE1 activation in B cells is still unclear. In B cells,
XBP1 activation is not impaired by IgM deficiency [27,28]
suggesting that massive immunoglobulin production per se
is not the cause of XBP1s activation and that IRE1/XBP1
activation may by part of a preemptive differentiation program
rather than as a consequence of ER overload. In addition to
XBP1 activation, IRE1 ribonuclease activity has other func-
tions. Upon sustained and acute ER-stress, IRE1 may
contribute to the degradation of membrane-associated mRNAs
through a process known as regulated IRE1 dependent decay
or RIDD [27,29,30]. The exact role of RIDD is unknown. It is
unclear if it solely contribute to decreasing protein load in the
ER or is part of the induction of the apoptosis phase as sug-
gested by experiments showing increased ER-stress induced
apoptosis in cells in which IRE1 activity was manipulated to
promote RIDD activation [30,31].
PERK is an ER anchored kinase that upon activation oli-
gomerizes and autophosphorylate. It kinase activity phos-
phorylates the translation initiation factor EIF2a, transiently
decreasing overall protein translation. This helps reducing
folding requirements in the ER. By phosphorylating EIF2a at
serine 51 PERK inhibits the guanine nucleotide exchange
factor EIF2B, a factor involved in the recycling of EIF2a to its
active GTP-bound form [32e34]. EIF2a phosphorylation can
be targeted by phosphatases, such as Growth arrest and DNA-
damage inducible protein-34 (GADD34) [35,36] that
contribute to the resolution of the stress responses. Some
mRNA containing short open reading frames in their 50
untranslated region are induced when EIF2a is inhibited.
EIF2a phosphorylation can therefore promote the synthesis of
a specific subset of genes by increasing the translation of
selective mRNAs whose translation is inhibited in unstressed
cells. For example this mechanisms promote the translation of
activating transcription factor 4 (ATF4) a major regulator of
ER-stress. ATF4 is involved in various cellular responses
including, glutathione biosynthesis, amino acid import, and
resistance to oxidative stress [37e39]. PERK also phosphor-
ylates Nuclear Factor (erythroid-derived 2)-like 2 (NRF2),
a transcription factor that regulates oxidative stress responses
and a critical regulator of innate immune responses [32,40,41].
The third branch of the ER-stress pathway is mediated by
ATF6, the best-known member of a transmembrane protein
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factors. Upon ER-stress, ATF6 translocates to the Golgi where
it is processed by site 1 and site 2 proteases that sequentially
remove the luminal domain and the transmembrane anchor.
These cleavages release the transcriptionally active N-terminal
fragment of ATF6 (ATF6N) which relocates to nucleus where
it upregulates ER-stress induced genes related to protein
folding and lipid synthesis [34,42e44].
5. ER-stress and ER-signaling regulation of inflammation
and immune responses
Beyond the adaptation phase that restore ER homeostasis,
ER-stress as well as the activation of ER-signaling pathways
can impact on host immune functions and promote inflam-
mation [9,45]. ER-stress observed in inflammatory pathologies
determine the size, nature and duration of immune response
[1,3,46].
Several studies have showed that ER-stress might augment
inflammation. Mutations in mice that produce defects in protein
folding or in the ER-stress response pathways lead to sponta-
neous inflammation. Mice with a mutation impairing the
folding of MUC2, a mucin expressed in the Paneth and goblet
cells, show signs of ER-stress in the intestine and develop an
inflammatory phenotype similar to the inflammation observed
in inflammatory bowel disease (IBD) patients [4,47]. Patients
that carry misfolding mutations in the surfactant protein-C
(SFTPC) gene are characterized by ER-stress activation in
epithelial cells and develop hyper-inflammatory responses upon
viral infections [6,48]. Viruses are believed to contribute to the
onset of idiopathic pulmonary fibrosis (IPF) in these patients.
However the exact contribution of the infection in the induction
of ER-stress or the contribution of ER-stress to the upregulation
of inflammation-mediated lung fibrosis in these patients are still
open questions. Similarly mutations in the cystic fibrosis
transmembrane conductance regulator (CFTR), an ion trans-
porter, may cause ER-stress in bronchial epithelia cells that
become hyper-responsive and more susceptible to respiratory
infection. Hyper-responses to inflammatory stimuli have also
been shown in macrophages. Studies showed that HLA-B27
misfolding can induce ER-stress responses in macrophages
resulting in enhanced cytokine production and increased release
of type I interferon, upon stimulation with the TLR4 agonist
LPS. HLA-B27 misfolding is associated with susceptibility to
spondyloarthritides, a group of heterogeneous auto-
inflammatory diseases [8,49]. In an other autoinflammatory
disease, ER-retention of the TNF receptor (TNFR1) was shown
to contribute to increased cytokines production observed in
TNFR1-associated periodic syndrome (TRAPS) patients [10],
suggesting that perturbations in the ER could be directly linked
to the development of autoinflammatory syndromes. Most
autoinflammatory diseases have been associated with aberrant
inflammasome activation [12]. The inflammasome is a cyto-
solic multiprotein complex that senses pathogens and cellular
damage and leads to the activation of a central proteolytic
enzyme, caspase-1. The main function of the inflammasome is
the cleavage and maturation of a few key cytokines, includingIL-1b. These cytokines drive the initiation of inflammatory
cascades in patients. Because the inflammasome has been
shown to become activated upon ER-stress [14], it is possible
that loss of ER-homeostasis could directly drive IL-1b depen-
dent inflammation and contribute to the pathogenesis of
diseases including autoinflammatory syndromes such as
TRAPS, by directly driving inflammasome activation.
ER-stress is also involved in regulating another important
branch of the innate immune system: The Toll-like receptors
(TLRs) response. TLRs are type I transmembrane proteins
characterized by an extracellular leucine-rich domain and
a cytoplasmic domain harboring a TIR domain similar to the
cytoplasmic domain of the mammalian interleukin 1 receptor
(IL-1R). TLRs activation upon recognition of “Pathogen-Asso-
ciated Molecular Patterns” or PAMPs, results in initiation of
cellular signaling events including activation of transcription
factors, cytokine modulation, and upregulation of interferon-
stimulated genes, leading to inflammatory responses and the
release of antimicrobial molecules. Regulatory loops connecting
TLRs and ER-signaling have been described. For example,
TLR4 and TLR2 promote the mRNA maturation of XBP1s by
selectively triggering the IRE1 branch of the ER-stress response
while inhibiting the other branches of the ER-stress pathway
[16,18]. Therefore the activation of IRE1 and XBP1s by TLRs
does not trigger a full ER-stress response but an XBP1s depen-
dent program that synergizes with TLR signaling pathways. The
induction of XBP1s amplifies TLR responses leading to
increased cytokine production [16,18]. This demonstrates that
specific engagement of ER-signaling pathways in absence of ER-
stress can contribute to immunity. XBP1s activation in the
context of ER-stress can also enhance TLRs responses. Macro-
phages treated with pharmacological agents disrupting ER
homeostasis display a dramatically enhanced response to TLR4
and TLR2 activation [16,20]. The mechanisms by which XBP1s
enhances cytokine production is still unclear but may likely
involve XBP1 binding at cytokine promoters [21].
In addition to XBP1, the ER stress-induced transcription
factor C/EBP homologous protein (CHOP), is involved in the
upregulation of cytokines including IL-23 in the context of
dendritic cells undergoing both ER stress and TLR stimulation
[23]. Knockdown of CHOP in a monocytic cell line signifi-
cantly reduced the synergistic effects of ER-stress and TLRs
on IL-23 expression. Therefore diverse ER stress-related
transcriptional pathways can affect the nature of immune
responses (Fig. 3).
The ER-stress response and inflammation are inter-
connected through various additional mechanisms. The
production of reactive oxygen species (ROS), the activation of
the transcription factor nuclear factor-kB (NF-kB) and the
induction of acute-phase proteins have being linked to both
ER-stress and inflammatory responses [25]. Immune cells can
also respond to stress signals released by other tissues. A
recent report suggests that stressed cells can transmit (via a yet
to be defined stress signal) ER-stress conditions to macro-
phages, increasing inflammatory responses [27]. Incubation of
macrophages with cultured conditioned medium from ER-
stressed cells promotes IRE1 activation and protein
Fig. 3. TLR4 responses and ER-signaling are connected and synergize to
promote cytokine production. TLR4 activate the transcription factor XBP1 by
selectively activating the IRE1 kinase while decreasing the activation of ATF6
and PERK pathways as well as ElF2a activation. The activation of IRE1 and
XBP1 does not contribute to an ER-stress response. However, activated XBP1
amplifies TLR signaling by enhancing cytokine production. Similarly, if
CHOP and XBP1 are induced upon treatment with pharmacological agents,
they both may contribute to cytokine production.
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a more sustained proinflammatory response. Similarly injec-
tion into mice of media supernatant harvested from ER-
stressed cells elicit the upregulation of genes typically asso-
ciated with ER stress responses in the liver [27]. These
observations may indicate that loss of ER homeostasis in
tissues can be transmitted to the microenvironment and
immune cells to augment immune responses [31]. Whether
this phenomenon is relevant to the pathology of inflammatory
diseases characterized by the loss of ER-homeostasis in tissues
is an exciting question that remains to be addressed.
ER-stress pathways are also implicated in regulating
immunogenicity. It has been shown that in tumor cells dying
upon treatment with anticancer therapy, ER-stress promotes
cell-surface localization of factors involved in immunogenic
cell death [32,34]. Calreticulin is the best-characterized
immunogenic signal emerging from the ER. This ER-
resident chaperone delocalize on the cell surface where it
can act as an “eat me” or “danger” signal that primes immune
responses directed against the stressed cell [35]. The exposure
of calreticulin on the cell surface is associated with the
induction of ER-stress [37,39] and may directly involve the
activation of ER-stress signaling pathways such as the PERK
pathway [32]. Therefore ER-stress specific signal may
increase immunogenicity by tagging the cell as stressed
[34,34,42].6. Induction of ER-stress and ER-signaling pathways by
pathogens
Pathogens activate ER-signaling pathways such as IRE1 by
directly engaging innate immune receptors as it was shown for
TLRs, however live pathogens affect also directly ER func-
tions as part of their infectious and replicative cycle [9].In plants, the ntbZIP60 gene (a signaling branch of the
plant ER-stress response related to ATF6) is activated upon
infection of tobacco leaves with Pseudomonas cichorri.
Moreover, silencing of ntbZIP60 allows higher multiplication
of P. cichorri compared to control plants [46], suggesting that
ER-stress pathways may represent an ancestral mechanism of
immune regulation. In Caenorhabditis elegans infected with
bacteria expressing pore-forming toxins, XBP1s and ATF6 are
induced [47]. Genetic studies have shown that these ER-stress
signaling pathways augment survival of infected worms
probably by promoting a protective restoration of ER
homeostasis or by increasing immune responses. Similarly in
C. elegans infected with Pseudomonas aeruginosa, activation
of IRE1 and XBP1 was noted [48]. In this model, XBP1
deficiency decreases viability, possibly due to a reduced ability
to cope with loss of ER-homeostasis in these worms [49].
Several types of virus, parasite and bacterium that infect
humans have been shown to perturb the ER and to manipulate
ER-signaling pathways as a mechanism aimed at interfering
with host immune responses and supporting replication.
Viruses are obligate intracellular pathogens that depend on the
host machinery to produce large amounts of infectious viral
particles. Many viruses depend on ER-membranes for trans-
lation and budding of viral particles, a process that can result
in the alteration of ER-homeostasis and therefore affect
immune responses [50]. In humans, ER-stress was detected in
tissues infected with different viruses. For example, XBP1
splicing and CHOP upregulation was detected in duodenal
biopsies from individuals infected with HIV compared to
uninfected persons [51]. ER-stress was also observed in the
liver of patients with chronic hepatitis C (HCV) [52]. Parasites
such as Toxoplasma gondii activate the ER-stress response
[53]. Loss of ER-homeostasis was also observed upon infec-
tion with different bacteria. CHOP induction, EIF2a phos-
phorylated and IRE1 activation was observed in macrophage-
rich areas of granulomas in lungs of mice infected with
virulent Mycobacterium tuberculosis (Mtb) [54]. ER-stress
activation by live bacteria can also occur prior to cell host
invasion. The facultative intracellular pathogen Listeria mon-
ocytogenes (Lm) was found to induce ER expansion and ER-
stress signaling pathways prior to host cell entry [55].
The monitoring of genes typically associated with ER-
stress responses is the main feature used to identify the acti-
vation of ER-signaling pathways. However recent studies
demonstrate that pathogens can trigger a specific branch of the
ER-stress program independently of the other branches
without engaging a full ER-stress response and upregulating
genes characteristic of ER-stress responses. Influenza A virus
activates the IRE1 pathway with little or no parallel activation
of the PERK and the ATF6 pathways. IRE1 activation is
apparently important for viral replication. Inhibition of IRE1
blocked Influenza A virus replication [56], demonstrating that
the virus may manipulate the IRE1 and benefit from it. Acute
infection with lymphocytic choriomeningitis virus (LCMV)
was shown to trigger a selective induction of the ATF6-
regulated branch of the ER-stress response, whereas PERK
and IRE1 pathways are neither activated nor blocked [57].
1298 F. Martinon / Microbes and Infection 14 (2012) 1293e1300How viruses trigger specific ER-signaling pathways is unclear.
In the case of LCMV, activation of ATF6 may involve the viral
glycoprotein precursor (GPC) [57], further suggesting that
some viruses may directly regulate these pathways indepen-
dently of the induction of ER-stress.
While many pathogens trigger ER-stress and/or features
associated with the ER-stress response, the exact function of
these pathways are still poorly understood. Activation of ER-
stress and ER-signaling pathways may increase immunity and
reduce the cellular stress associated with the infection. This is
a recent hypothesis and few experimental evidences demon-
strate the physiological importance of these pathways in regu-
lating pathogen replication and immunity in vivo. Importantly,
the key role of these pathways is also highlighted by the fact that
pathogen have evolvedmechanisms tomanipulate ER-signaling
pathways optimizing survival and replication.
7. Regulation of ER-signaling pathways by pathogens
The role of the ER-stress pathways in shaping immunity is
underscored by the fact that pathogens as well as innate
immunity pathways regulate ER-stress responses. It has been
shown for example that the ATF4-CHOP branch of the PERK
pathway is specifically inhibited by TLR signaling [58].
Activation of TRIF by TLRs activates a phosphatase, PP2A,
that dephosphorylate a subunit of EIF2B (guanine nucleotide
exchange factor for EIF2a) leading to the inhibition of phos-
phorylated EIF2a activity and downregulation of PERK
mediated ATF4 and CHOP upregulation [59]. In macrophages
TLR signaling has been found to inhibit ATF6 and PERK
activation by a mechanism yet to be identified [16]. This
regulation of ER-signaling responses by innate immunity may
explain why TLRs in macrophages only activate IRE1 and in
absence of concomitant activation of PERK and ATF6,
therefore, favoring an inflammatory response rather than a full
ER-stress response.
Viruses are also able to manipulate the ER-stress response
by altering specific pathways or changing cellular homeostatic
setpoints. Dengue fever virus (DENV) for example, manipu-
lates the ER-signaling pathways to specifically activate and
suppress the three different branches of the ER-stress
response. Importantly each branch is regulated differently
depending on timing and the infectious stage [60], suggesting
that the virus can specifically manipulate the system to
increase survival and prolong the viral life cycle. HCV
provides us with another example of time-dependent regula-
tion of the ER-stress response. This virus triggers the ER-
stress response in a wave-like fashion, which peaks a few
days after infection. Then the hepatocytes become tolerant to
the stress induced by the virus or by chemical agents.
Suppression of viral replication restore the ability to engage an
ER-stress response suggesting that, the virus itself is can
regulate the response [61]. In line with these observations,
livers from patients with untreated chronic hepatitis C exhibit
activation of the three ER-stress branches without apparent
induction of downstream ER-related responsive genes [52].
These findings could be explained by specific dampening ofthe downstream response by viral effectors. It has been shown
that HCV reduces XBP1 transcriptional activity [62] and that
the HCV envelope protein E2 may regulate PERK activity
[63]. Similar observations were reported for coronavirus
mouse hepatitis virus (MHV). Infection by MHV induces
IRE1-mediated splicing of XBP1 mRNA and the maturation of
ATF6, without upregulating significant downstream target
genes [64]. Likewise, the influenza virus and the Enterovirus
71 (EV71) modulate the stress response in the setting of
a preexisting stress by dampening the activation and pro-
cessing of the ATF6 as indicated by its inhibitory effect on
ATF6-dependent genes [56,65]. Parasites can also modulate
ER-signaling responses. The host ATF6 pathway is targeted by
the T. gondii virulence factor ROP18 [53]. ROP18 is a kinase
that triggers proteasome-dependent degradation of ATF6
a process that apparently is required for parasite virulence.
These examples demonstrate that pathogens have evolved
distinct mechanisms to regulate and benefit from ER-signaling
pathways. Cells that undergo acute pressure on the ER may
trigger an apoptosis program as part of a cellular response to
acute dysfunction. It is therefore likely that the dampening of
this response by pathogens may increase it life cycle by
promoting survival of host cells. Alternatively, the pathogen
may also manipulate the system to specifically control tran-
scriptional programs triggered by the ER-stress signaling
branches independently of the ER-stress response. The exact
function of these programs in the context of an infection
in vivo is unclear. The regulation of inflammatory and immune
functions as well as the induction of pathogen specific tran-
scriptional programs may represent key mechanisms orches-
trated by pathogens takeover of ER-signaling pathways.
8. Conclusion
The overall message of this review is that ER-signaling
pathways steaming from the ER are often tightly linked to
inflammation and immunity. The ER is therefore a central
stress sensor that detects cellular insults and trigger specific
responses involved in restoring homeostasis as well as
promoting immunity. However, there are many knowledge
gaps that need to be investigated in order to have a compre-
hensive picture of how innate immune signaling pathways
intersect with signaling branches emerging from the ER. The
challenge for the future is to characterize at the molecular
level the proximal pathways that emerge from the ER-stress
signaling pathways and to understand how these branches
are activated and regulated by pathogens, pathogen virulence
factors as well as innate immune signaling component such as
TLRs. ER-stress is often defined by the induction of the ER-
stress response, however it is now clear that pathogen as
well as inflammatory condition can operate ER-signaling
pathways in absence of ER-stress. The development of new
techniques and reagents to monitor the stress in the ER as well
as the activation of ER-signaling branches will foster a better
characterization of these pathways in immunity. Deficiencies
in the main components of the ER-signaling pathways are
generally lethal in mice. The development of new mouse
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pathways may therefore help assess the physiological impor-
tance of these responses during the course of infections as well
as in autoimmune and autoinflammatory diseases. It will be
also important to understand how ER-signaling pathways
affect immune responses in cooperation with other stress
responses related to the proteostasis network such as auto-
phagy and the oxidative stress response. Finally, it is tempting
to speculate that the development of drugs to alleviate ER-
stress or regulate specific branches of the ER-stress response
may provide new therapeutic approaches in the regulation of
infectious and immune-related diseases.
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